RxSight, Inc. ($RXST)
Filing Information
| Accession Number | 0001193125-26-386838 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 10, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
1,589,266
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Stock option (right to buy) | Derivative | Sep 5, 2026 | Sale to Issuer | 338,819 | โ | โ | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (right to buy) | Derivative | Sep 5, 2026 | Sale to Issuer | 200,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (right to buy) | Derivative | Sep 5, 2026 | Sale to Issuer | 149,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (right to buy) | Derivative | Sep 5, 2026 | Sale to Issuer | 215,000 | โ | โ | 0 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (right to buy) | Derivative | Sep 5, 2026 | Grant/Award | 254,751 | โ | โ | 254,751 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (right to buy) | Derivative | Sep 5, 2026 | Grant/Award | 173,913 | โ | โ | 173,913 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (right to buy) | Derivative | Sep 5, 2026 | Grant/Award | 96,129 | โ | โ | 96,129 | Direct | โ | View Details | |
Chief Medical Officer | Stock Option (right to buy) | Derivative | Sep 5, 2026 | Grant/Award | 161,654 | โ | โ | 161,654 | Direct | โ | View Details |